Manulife (Manufacturers Life Insurance)’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.55M | Sell |
150,027
-20,581
| -12% | -$350K | ﹤0.01% | 1408 |
|
|
2025
Q1 | $3.33M | Buy |
170,608
+27,106
| +19% | +$529K | ﹤0.01% | 1316 |
|
|
2024
Q4 | $3.56M | Sell |
143,502
-2,349
| -2% | -$58.3K | ﹤0.01% | 1331 |
|
|
2024
Q3 | $3.57M | Buy |
145,851
+8,762
| +6% | +$215K | ﹤0.01% | 1353 |
|
|
2024
Q2 | $3.21M | Buy |
137,089
+32,279
| +31% | +$756K | ﹤0.01% | 1332 |
|
|
2024
Q1 | $3.46M | Buy |
104,810
+70,186
| +203% | +$2.32M | ﹤0.01% | 1327 |
|
|
2023
Q4 | $942K | Buy |
34,624
+1,109
| +3% | +$30.2K | ﹤0.01% | 1830 |
|
|
2023
Q3 | $806K | Buy |
33,515
+6,108
| +22% | +$147K | ﹤0.01% | 1858 |
|
|
2023
Q2 | $875K | Buy |
27,407
+1,997
| +8% | +$63.8K | ﹤0.01% | 1730 |
|
|
2023
Q1 | $778K | Sell |
25,410
-170
| -0.7% | -$5.21K | ﹤0.01% | 1753 |
|
|
2022
Q4 | $1M | Buy |
25,580
+343
| +1% | +$13.4K | ﹤0.01% | 1608 |
|
|
2022
Q3 | $1.2M | Sell |
25,237
-468
| -2% | -$22.3K | ﹤0.01% | 1532 |
|
|
2022
Q2 | $995K | Buy |
25,705
+4,471
| +21% | +$173K | ﹤0.01% | 1651 |
|
|
2022
Q1 | $1.22M | Sell |
21,234
-4,516
| -18% | -$259K | ﹤0.01% | 1667 |
|
|
2021
Q4 | $2.05K | Buy |
25,750
+453
| +2% | +$36 | ﹤0.01% | 1492 |
|
|
2021
Q3 | $2.2M | Sell |
25,297
-993
| -4% | -$86.4K | ﹤0.01% | 1473 |
|
|
2021
Q2 | $3.38M | Buy |
26,290
+4,070
| +18% | +$524K | ﹤0.01% | 1427 |
|
|
2021
Q1 | $1.78M | Sell |
22,220
-1,389
| -6% | -$111K | ﹤0.01% | 1603 |
|
|
2020
Q4 | $1.93M | Buy |
23,609
+3,813
| +19% | +$311K | ﹤0.01% | 1546 |
|
|
2020
Q3 | $487K | Buy |
+19,796
| New | +$487K | ﹤0.01% | 2019 |
|